About MiMedx Group
MiMedx Group is a company based in Marietta (United States) founded in 1985.. The company has 837 employees as of December 31, 2024. MiMedx Group has completed 2 acquisitions, including SpineMedica and Stability Biologics. MiMedx Group offers products and services including EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, and AXIOFILL. MiMedx Group operates in a competitive market with competitors including Theradaptive, Ossio, RevBio, Aziyo Biologics and EpiBone, among others.
- Headquarter Marietta, United States
- Employees 837 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mimedx Group, Inc
-
Annual Revenue
$348.88 M8.52as on Dec 31, 2024
-
Net Profit
$42.42 M-27.15as on Dec 31, 2024
-
EBITDA
$62.35 M53.8as on Dec 31, 2024
-
Latest Funding Round
$100 M (USD), Post-IPO
Jul 02, 2020
-
Investors
Hayfin
& 2 more
-
Employee Count
837
as on Dec 31, 2024
-
Investments & Acquisitions
SpineMedica
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of MiMedx Group
MiMedx Group is a publicly listed company on the NASDAQ with ticker symbol MDXG in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of MiMedx Group
MiMedx Group offers a comprehensive portfolio of products and services, including EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, and AXIOFILL. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Placental tissue product for promoting wound healing in patients.
Biologic for wound care to support tissue regeneration effectively.
Product aiding surgical healing with placental materials.
Biologic for surgical applications to enhance recovery processes.
Material for surgical use in tissue repair and support.
Unlock access to complete
Leadership Team
130 people
Sales and Marketing
37 people
Senior Team
12 people
Product Management Team
10 people
Software Development Team
10 people
Finance and Accounting
8 people
Operations Team
7 people
Legal and Compliance
7 people
Unlock access to complete
Funding Insights of MiMedx Group
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $100.0M
-
First Round
First Round
(01 May 2009)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Post-IPO - MiMedx Group | Valuation |
investors |
|
| Jun, 2019 | Amount | Debt – Conventional - MiMedx Group | Valuation |
investors |
|
| Dec, 2013 | Amount | Post-IPO - MiMedx Group | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MiMedx Group
MiMedx Group has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Hayfin, EW Healthcare Partners and Blue Torch Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location | |
|
Private debt investments are directed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Blue Torch Capital is engaged in private credit investment management.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MiMedx Group
MiMedx Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include SpineMedica and Stability Biologics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bone and skin tissues are developed for medical grafting applications.
|
2010 | ||||
|
Spine alignment devices and artificial spinal implants
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - MiMedx Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mimedx Group Comparisons
Competitors of MiMedx Group
MiMedx Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theradaptive, Ossio, RevBio, Aziyo Biologics and EpiBone, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic delivery platform is developed for orthopedic clinical indications.
|
|
| domain | founded_year | HQ Location |
Orthopedic fixation is enabled by bone regeneration biocomposite technology.
|
|
| domain | founded_year | HQ Location |
Synthetic adhesives for bone and dental repair are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
|
| domain | founded_year | HQ Location |
Developer of stem cells to regrow damaged bones
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mimedx Group
Frequently Asked Questions about MiMedx Group
When was MiMedx Group founded?
MiMedx Group was founded in 1985 and raised its 1st funding round 24 years after it was founded.
Where is MiMedx Group located?
MiMedx Group is headquartered in Marietta, United States. It is registered at Marietta, Georgia, United States.
How many employees does MiMedx Group have?
As of Dec 31, 2024, the latest employee count at MiMedx Group is 837.
What is the annual revenue of MiMedx Group?
Annual revenue of MiMedx Group is $348.88M as on Dec 31, 2024.
What does MiMedx Group do?
MiMedx Group was founded in 1985 and is headquartered in Marietta, United States. Operations center on regenerative medicine within the biomaterials sector, where products are processed from human amniotic membranes and collagen fibers for applications in wound care, surgery, sports medicine, and orthopedics. Key technologies encompass AmnioFix and EpiFix from donated placentas, CollaFix with cross-linked polymers, and OrthoFlo as an amniotic fluid allograft for tissue repair.
Who are the top competitors of MiMedx Group?
MiMedx Group's top competitors include EpiBone, Theradaptive and Ossio.
What products or services does MiMedx Group offer?
MiMedx Group offers EPIFIX, EPICORD, AMNIOFIX, AMNIOCORD, and AXIOFILL.
Is MiMedx Group publicly traded?
Yes, MiMedx Group is publicly traded on NASDAQ under the ticker symbol MDXG.
How many acquisitions has MiMedx Group made?
MiMedx Group has made 2 acquisitions, including SpineMedica, and Stability Biologics.
Who are MiMedx Group's investors?
MiMedx Group has 3 investors. Key investors include Hayfin, EW Healthcare Partners, and Blue Torch Capital.
What is MiMedx Group's ticker symbol?
The ticker symbol of MiMedx Group is MDXG on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.